| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1644667-47-9 | (±)-rel-(2S,4S)-benzyl 2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate | C20H20N2O3 |
| 1644667-56-0 | (-)-(2S,4S)-Benzyl 2-(4-Cyanophenyl)-4-Hydroxypiperidine-1-Carboxylate | C20H20N2O3 |
| 1644667-59-3 | 4-{(2S,4S)-1-[(Benzyloxy)carbonyl]-4-ethoxy-2-piperidinyl}benzoic acid | C22H25NO5 |
| 1644667-62-8 | Rel-methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate | C15H21NO3 |
| 1644670-37-0 | Iptacopan | C25H30N2O4 |
| 1645286-75-4 | rel-2-[4-[6-[(3R,5S)-3,5-Dimethyl-1-piperazinyl]-4-methyl-3-pyridinyl]phenyl]-3,7-dihydro-7-methyl-4H-pyrrolo[2,3-d]pyrimidin-4-one | C25H28N6O |
| 1646355-34-1 | 7-(2-Butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione | C22H23N7O2 |
| 1646839-59-9 | ONO-7475 | C32H26N4O6 |
| 1646862-02-3 | Dolutegravir intermediate 5 | C14H19NO8 |
| 1646862-07-8 | Cartegravir Impurity 07 | C20H19F2N3O5 |
| 1646862-08-9 | Cabotegravir Impurity 2 | C19H17F2N3O5 |
| 1646862-21-6 | Cartegravir Impurity 05 | C13H14N2O6 |
| 1646906-26-4 | 2,4,6-Tris[3-(diphenylphosphinyl)phenyl]-1,3,5-triazine | C57H42N3O3P3 |
| 1647008-46-5 | 8-Chlorobenzo[b]naphtho[1,2-d]furan | C16H9ClO |
| 1647073-46-8 | N-(Trifluoromethylthio)saccharin | C8H4F3NO3S2 |
| 1648562-63-3 | Fluticasone 21-Isobutyrate | C26H33F3O5S |
| 1648593-70-7 | (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1-[[(4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinolin-7-yl]carbonyl]-1H-indeno[5,4-f]quinoline-7-carboxamide | C46H55F6N3O4 |
| 1648707-58-7 | 3-Bromo-N-[3-[(1,1-dimethylethyl)amino]propyl]benzamide | C14H21BrN2O |
| 1648791-23-4 | 2-(4-Ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine | C29H43N5 |
| 1648825-53-9 | PhenoFluor(c)Mix | C27H36Cl2CsFN2 |
| 1649470-53-0 | 5-Fluoro-4-iodo-2-pyridinamine | C5H4FIN2 |
| 1650558-67-0 | 2-Phenyl-10H-oxazolo[5,4-a]carbazole | C19H12N2O |
| 1651214-74-2 | 4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C29H37N7O4 |
| 1651823-59-4 | [2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC][butylbis(tricyclo[3.3.1.13,7]dec-1-yl)phosphine](methanesulfonato-κO)-Palladium | C37H52NO3PPdS |
| 1651839-34-7 | Lycojaponicuminol C | C29H48O4 |
| 1651890-44-6 | 3'-Methyl-3''-[(1E)-2-phenylethenyl]-3,2':5',2'':5'',3'''-quaterpyridine | C29H22N4 |
| 1652561-87-9 | Sah-sos1A | C100H159N27O28 |
| 1652591-81-5 | GSK484 HCl | C27H32ClN5O3 |
| 1654737-32-2 | Valganciclovir Hydrochloride - Impurity R | C14H21ClN6O4 |
| 1654755-02-8 | 2-(2,6-Dimethoxyphenyl)-3-(diphenylphosphaneyl)-1-methyl-1H-indole | C29H26NO2P |
| 1654820-87-7 | 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2,3-dihydroxy-1-propanone | C25H26N6O4 |
| 1655514-74-1 | (11alpha)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione | C30H37NO4 |
| 1655514-79-6 | (17alpha)-17-Hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione cyclic 3,20-bis(1,2-ethanediyl acetal) | C24H34O5 |
| 1656996-83-6 | mPEG-Silane | |
| 1657014-33-9 | 2-(4-Butoxy-3-cyanophenyl)-4-methyl-5-thiazolecarboxylic acid | C16H16N2O3S |
| 1657017-43-0 | 3-(4-Chlorophenyl)-9-(2-naphthalenyl)-9H-carbazole | C28H18ClN |
| 1659301-59-3 | Rosuvastatin Impurity 3 | C22H25FN3O5S .Na |
| 1659305-78-8 | YAP-TEAD Inhibitor 1 | C93H144ClN23O21S2 |
| 1659317-57-3 | Atorvastatin calcium impurity 17 | C33H35CaFN2O4 |
| 1660114-31-7 | NIK SMI1 | C20H19N3O4 |
| 1660143-42-9 | Carfilzomib Impurity 8 | C40H57N5O6 |
| 1660153-91-2 | 2'-[(1,1-Dimethylethyl)phenylphosphino]-N2,N2,N6,N6-tetramethyl-[1,1'-biphenyl]-2,6-diamine | C26H33N2P |
| 1660156-04-6 | Cyclogrifolin | C22H30O2 |
| 1660957-78-7 | Bromhexine Impurity 01 | C13H19Br2ClN2 |
| 1660957-93-6 | Bromhexine EP Impurity E Chloride | C15H21Br2ClN2 |
| 1660963-42-7 | N-[3-[2-[[2,3-Difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide | C29H28F2N6O2 |
| 1661042-31-4 | (t-Bu)PhCPhos Pd G3 | C39H47N3O3PPdS- |
| 1661839-45-7 | 8-[3-Chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one | C23H24ClN5O |
| 1661854-97-2 | (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide | C23H20N6O |
| 1662688-20-1 | Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH | C64H101N5O16 |